Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimiliano Calabrese

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Neuroimaging Clinics of North America|April 11, 2017
Cortical Gray Matter MR Imaging in Multiple SclerosisMassimiliano Calabrese, Marco Castellaro
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 3, 2014
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: yesMassimiliano Calabrese, Nicola De Stefano
Expert Opinion on Therapeutic Targets|September 9, 2020
The BAFF / APRIL system as therapeutic target in multiple sclerosisRoberta Magliozzi, Damiano Marastoni, Massimiliano Calabrese
Nature Reviews. Neurology|July 14, 2010
Cortical lesions in multiple sclerosisMassimiliano Calabrese, Massimo Filippi, Paolo Gallo
Diagnostics (Basel, Switzerland)|January 21, 2022
"What Is Hidden behind the Mask?" Facial Emotion Recognition at the Time of COVID-19 Pandemic in Cognitively Normal Multiple Sclerosis PatientsStefano Ziccardi, Francesco Crescenzo, Massimiliano Calabrese
Expert Review of Neurotherapeutics|November 14, 2014
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophyMassimiliano Calabrese, Alberto Gajofatto, Maria Donata Benedetti
Multiple Sclerosis and Related Disorders|July 11, 2020
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern ItalyFrancesco Crescenzo, Damiano Marastoni, Chiara Bovo, et al.
Prion|October 25, 2012
Grey matter lesions in MS: from histology to clinical implicationsMassimiliano Calabrese, Alice Favaretto, Valeria Martini, et al.
Journal of Neurology|March 12, 2004
The clinical impact of interferon beta antibodies in relapsing-remitting MSPaola Perini, Massimiliano Calabrese, Giovanni Biasi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Cyclophosphamide-based combination therapies for autoimmunityPaola Perini, Massimiliano Calabrese, Luciano Rinaldi, et al.
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Neuroimaging Clinics of North America|April 11, 2017
Cortical Gray Matter MR Imaging in Multiple SclerosisMassimiliano Calabrese, Marco Castellaro
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 3, 2014
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: yesMassimiliano Calabrese, Nicola De Stefano
Expert Opinion on Therapeutic Targets|September 9, 2020
The BAFF / APRIL system as therapeutic target in multiple sclerosisRoberta Magliozzi, Damiano Marastoni, Massimiliano Calabrese
Nature Reviews. Neurology|July 14, 2010
Cortical lesions in multiple sclerosisMassimiliano Calabrese, Massimo Filippi, Paolo Gallo
Diagnostics (Basel, Switzerland)|January 21, 2022
"What Is Hidden behind the Mask?" Facial Emotion Recognition at the Time of COVID-19 Pandemic in Cognitively Normal Multiple Sclerosis PatientsStefano Ziccardi, Francesco Crescenzo, Massimiliano Calabrese
Expert Review of Neurotherapeutics|November 14, 2014
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophyMassimiliano Calabrese, Alberto Gajofatto, Maria Donata Benedetti
Multiple Sclerosis and Related Disorders|July 11, 2020
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern ItalyFrancesco Crescenzo, Damiano Marastoni, Chiara Bovo, et al.
Prion|October 25, 2012
Grey matter lesions in MS: from histology to clinical implicationsMassimiliano Calabrese, Alice Favaretto, Valeria Martini, et al.
Journal of Neurology|March 12, 2004
The clinical impact of interferon beta antibodies in relapsing-remitting MSPaola Perini, Massimiliano Calabrese, Giovanni Biasi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Cyclophosphamide-based combination therapies for autoimmunityPaola Perini, Massimiliano Calabrese, Luciano Rinaldi, et al.
Pageof 17